Effectiveness of omega-3 fatty acids versus placebo in subjects at ultra-high risk for psychosis: the PURPOSE randomized clinical trial.

Author(s):
Winter-van Rossum, I.; Slot, M.I.E.; van Hell, H.H.; Bossong, M.G. (0000-0001-7880-2300); Berger, G.; Aschauer, H.; Maat, A.; Walitza, S.; Lavan, O.; Baeza, I.; Dolz, M.; Monducci, E.; Fiori Nastro, P.; Kroken, R.A.; Lawrie, S.M.; Díaz-Caneja, C.M.; Renner, T.; Schlögelhofer, M.; Scharinger, C.; Spalletta, G.; Banaj, N.; Otero, S.; Schipper, M.; Kwakkel, D.B.; PURPOSE Study Group; Kahn, R.S.
Published
2025
Publication type
Article / Letter to editor
Date issued
2025-07-07
Language
English
Is part of
Schizophrenia Bulletin (2025), Vol. 51, p. 1082-1091
hdl
1887/4282823
doi
10.1093/schbul/sbae186